Guardant Health, Inc. (GH)
102.07
+0.69
(+0.68%)
USD |
NASDAQ |
Dec 12, 16:00
101.80
-0.27
(-0.26%)
After-Hours: 20:00
Guardant Health Research and Development Expense (Quarterly): 89.96M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| EXACT Sciences Corp. | 117.22M |
| Quest Diagnostics, Inc. | -- |
| Illumina, Inc. | 228.00M |
| Natera, Inc. | 173.41M |
| Delcath Systems, Inc. | 7.986M |